Please login to the form below
DH
This page shows the latest DH news and features for those working in and with pharma, biotech and healthcare.
UK appoints pharma veteran to 'streamline' NHS costs
The UK has recruited pharma veteran Steve Oldfield to fill the newly-created role of chief commercial officer at the Department of Health (DH). ... His extensive experience in senior pharmaceutical roles as UK managing director for Sanofi and Teva will
Latest news
-
Sarah Matthew crowned Healthcare Communiquétor 2017
So much of her senior consulting is confidential that few people know of her amazing achievements with leading industry bodies such as the ABPI and the DH, and with industry leaders
-
Pharma could make more of its real world evidence
The report, published in February 2016, says it is 'unacceptable' that, six years after the CDF was set up, the DH and NHS England still do not have data to evaluate ... When the CDF was introduced in 2010, the DH 'encouraged' trusts to collect data to
-
UK pharma rebate payment doubles in one year
The ABPI, which negotiated the deal with DH in 2013, is keen to see this as 'underwriting' the NHS medicines bill.
-
Is a UK market access shake-up on the cards?
But the secrecy around these deals irks health economists and doctor groups, as without knowing how much has been knocked off the price that no one outside NICE, the DH and ... I do, however, think there are issues about these commercially confidential
-
Pharma must engage on the affordability question, says ABPI
The rebates should be helping this, but the ABPI and many other senior executives in the industry told PMLiVE that this money is going back to the DH and NHS England,
More from news
Approximately 2 fully matching, plus 167 partially matching documents found.
Latest Intelligence
-
Public affairs
Healthcare terms - Public affairs.
-
Healthcare systems
Healthcare terms - Healthcare systems.
-
Pharma perspectives: communications creativity (part 2)
Is pharma marketing less creative than its consumer sector? DH: That old chestnut eh! ... DH: The simple answer is yes! How we do it is another matter.
-
NICE and ‘ultra orphans’
Provisional evaluation topics chosen by the Department of Health (DH). Consultees and commentators identified. ... Scope prepared by NICE and DH. Evaluation topics officially referred to NICE by DH.
-
Drug pricing in Ireland
The agreement between the Department of Health (DH), the Health Service Executive (HSE) and the Irish Pharmaceutical Healthcare Association (IPHA) will lead to significant reductions in the prices of both ... The three-year pricing agreement. The latest
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
New health ministers and re-appointments after reshuffle
Two noticeable absences are Lord Freddy Howe, who has moved out of the DH and over to the Ministry of Defence and David Willetts, formerly the universities and science minister, who
-
UK names guardian for national health data
The UK's Department of Health (DH) has appointed Dame Fiona Caldicott as the nation's guardian for health and care data. ... According to the DH, Dame Fiona will be the “ patients' champion on security of personal medical information” to guarantee
-
NHS names ‘procurement champion’
This broad experience is likely to have been one of the reasons the DH was keen to appoint Lord Carter to his new position.
-
New chair of the British Pharmacopoeia Commission
The UK's Department of Health (DH) has named Prof Kevin Taylor as the new chair of the British Pharmacopoeia Commission (BPC).
-
DH names new chief executive of the MHRA
DH names new chief executive of the MHRA. Ian Hudson to lead UK medicines regulator.
More from appointments
Approximately 2 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
Digitas Health
Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals. Creatively driven, media savvy, technology fueled, Digitas Health is a leading brand
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Business Unit Head, Medical Communications, London
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- MaxCyte gets green light for solid tumour cell therapy
- Brexit rebels win vote on European Medicines Agency alignment
- Positive mid-stage trial gives Allergy’s investors some welcome relief
- OUTiCO growth in multi-channel creates more job openings
- Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO
- Ashfield Meetings & Events welcomes largest intake of students in seventh year of undergraduate placement scheme
- AstraZeneca joins Merck in Brexit stockpiling effort
- Vyriad inks immunotherapy alliance with Merck/Pfizer
- Huntsworth buys Giant Creative Strategy
PMHub
SpotMe
SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
